
API and parent drug
Lumateperone
CAS 313368-91-1 · C24H28FN3O · 9 related records
01API identity and structure

| API / medicine name | Lumateperone |
|---|---|
| CAS RN | 313368-91-1 |
| PubChem CID | 21302490 |
| Molecular formula | C24H28FN3O |
| Molecular weight | 393.5 g/mol |
| IUPAC name | 1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one |
| Defined stereocentres | 2 |
| Unassigned stereocentres | 0 |
| SMILES | CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F |
|---|---|
| InChI | Not listed |
| InChIKey | HOIIHACBCFLJET-SFTDATJTSA-N |
02Stereochemistry
The published structure contains 2 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.
Published same-connectivity configurations
4 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.



![2D structure: 1-(4-fluorophenyl)-4-((6bS,10aR)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one methylbenzenesulfonate](/structures/pubchem/69471377/no-cas-1-4-fluorophenyl-4-6bs-10ar-3-methyl-2-3-6b-9-10-10a-hexahydro-1h-pyrido-3-4-4-5-pyrrolo-1-2d-structure-300.png)
1-(4-fluorophenyl)-4-((6bS,10aR)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one methylbenzenesulfonate
CAS Not listed
HOIIHACBCFLJET-NHCUHLMSSA-N
2 defined, 0 unassigned centres
Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
03Structural nitrosamine screen
No record-level structural candidate is currently published for this identity.
This result does not predict manufacturing conditions, formation, analytical findings or absence of risk. A process-specific assessment is required.
04India status for this compound
The result below applies only to this exact compound identity and CAS number.
| NDPS / RCS | NOT FOUND IN REVIEWED ENTRIES | No exact reviewed identity entry was found. Generic, class, analogue, salt and isomer provisions were not evaluated. Confirm the current official schedule before a regulatory decision. |
|---|---|---|
| SCOMET | NOT FOUND IN REVIEWED CAS ENTRIES | CAS 313368-91-1 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · source version 1985-09-16
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · source version 2026-03-11
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · source version 2024-09-02
06Sources
- S01PubChem compound record, CID 21302490
Structure, identifiers and machine-readable properties for the API identity.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. Vendor descriptions and contributed narrative text are not reproduced.
- S03Lazychem chemical records
Parent-family links use the supplied parent identity.

![2D structure: (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, CAS 313368-85-3](/structures/pubchem/21302499/313368-85-3-6br-10as-3-methyl-2-3-6b-7-8-9-10-10a-octahydro-1h-pyrido-3-4-4-5-pyrrolo-1-2-3-de-quinoxa-2d-structure-300.png)





